New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
KORU Medical Systems, Inc.
KRMD
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

123M

Medical - Instruments & Supplies

Next Earning date - 13 Nov 2024

123M

Medical - Instruments & Supplies

Next Earning date - 13 Nov 2024

2.69USD
Shape0.04 ( 1.51%)
favorite-chart

Relative Strenght

21
favorite-chart

Volume Buzz

-91%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

13%

Quote Panel

Shape
Updated October 4, 2024
1W -1.47 % 1M 8.91 % 3M 6.75 % 1Y 2.28 %

Key Metrics

Shape
  • Market Cap

    123.35M


  • Shares Outstanding

    45.86M


  • Share in Float

    43.16M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    2.69


  • Average Volume

    69607


  • Beta

    0.418


  • Range

    1.978-3.09


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.korumedical.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

4.00x

P/S Ratio

6.59x

P/B Ratio

0.2

Debt/Equity

-38.2%

Net Margin

$-0.3

EPS

How KRMD compares to sector?

P/E Ratio

Relative Strength

Shape

KRMD

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$38M

Shape349%

2025-Revenue

$0.09

Shape-305%

2025-EPS

$4M

Shape-266%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

B. Riley

initialise

Previous: Not converted

2023-09-07

Now: Buy

Piper Sandler

upgrade

Previous: Not converted

2022-11-10

Now: Overweight

Canaccord Genuity

upgrade

Previous: Not converted

2022-11-10

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.03
vs -0.02

Q4.22

arrow
arrow

N/A

-0.04
vs -0.02

Q1.23

arrow
arrow

N/A

-0.05
vs -0.05

Q2.23

arrow
arrow

N/A

-0.05
vs -0.06

Q3.23

arrow
arrow

N/A

-0.03
vs -0.03

Q4.23

arrow
arrow

N/A

-0.02
vs -0.04

Q1.24

arrow
arrow

N/A

-0.02
vs -0.05

Q2.24

arrow
arrow

N/A

-0.02
vs -0.05

Q3.24

arrow
arrow

N/A

-0.04
vs -0.03

Q4.24

arrow
arrow

N/A

-0.04
vs -0.02

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+28%

7.8M  vs 6M

Q4.22

arrow
arrow

+13%

7.3M  vs 6.5M

Q1.23

arrow
arrow

+18%

7.4M  vs 6.2M

Q2.23

arrow
arrow

+6%

6.9M  vs 6.5M

Q3.23

arrow
arrow

-10%

7M  vs 7.8M

Q4.23

arrow
arrow

-2%

7.2M  vs 7.3M

Q1.24

arrow
arrow

+11%

8.2M  vs 7.4M

Q2.24

arrow
arrow

+22%

8.4M  vs 6.9M

Q3.24

arrow
arrow

+10%

7.7M  vs 7M

Q4.24

arrow
arrow

+11%

8M  vs 7.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-4%

-0.04
vs -0.09

Q4.22

arrow
arrow

-6%

-0.06
vs -0.04

Q1.23

arrow
arrow

-8%

-0.08
vs -0.06

Q2.23

arrow
arrow

-9%

-0.09
vs -0.08

Q3.23

arrow
arrow

-5%

-0.05
vs -0.09

Q4.23

arrow
arrow

-37%

-0.37
vs -0.05

Q1.24

arrow
arrow

-10%

-0.10
vs -0.37

Q2.24

arrow
arrow

-5%

-0.05
vs -0.10

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

35

35
vs 34

3%

Q4.22

arrow
arrow

41

41
vs 35

17%

Q1.23

arrow
arrow

56

56
vs 41

37%

Q2.23

arrow
arrow

64

64
vs 56

14%

Q3.23

arrow
arrow

57

57
vs 64

-11%

Q4.23

arrow
arrow

60

60
vs 57

5%

Q1.24

arrow
arrow

60

60
vs 60

NA

Q2.24

arrow
arrow

64

64
vs 60

7%

Earnings Growth

Latest News